S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 64,097.62 +0.31%
Next Bullish Trade
Sign in
BAYRY

Bayer Aktiengesellschaft OQX · BAYRY

$13.80 +0.20 (+1.47%)
Extended · +1.34σ

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · BAYRY

Momentum reads · latest daily bar
Last
$13.80
+0.20 (+1.47%)
Mkt cap
$54.2B
Healthcare
RSI(14)
61.7
neutral
Stochastic %K
41.6
neutral
MFI(14)
40.1
neutral
ADX(14)
31.5
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $13.4B $2.8B $3.5B $-2.2B 20.6% 26.3%
2025-12-31 $11.4B $-3.8B $4.3B $3.4B -32.8% 38.0%
2025-09-30 $9.7B $-1.0B $-0.5B $0.8B -10.0% -5.6%
2025-06-30 $10.7B $-0.2B $0.0B $0.6B -1.9% 0.1%
2025-03-31 $13.7B $1.3B $2.3B $-1.4B 9.5% 16.9%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare BAYRY vs peers

Line BAYRY up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing BAYRY UNH× AMZN× JNJ×
Verdict
Weighted score 0-100 across 4 tickers · best in green
#3
BAYRY
score 51.2
5/5 inputs
Ranks third because zero sentiment score heavily drags overall despite strong 80 value score with 13.5% FCF yield.
value 80growth 50quality 33momentum 68sentiment 0
#2
UNH
score 61.5
3/5 inputs
Ranks second with perfect 100 sentiment score from 23% insider buying offsetting critically low 11 quality rating.
quality 11momentum 70sentiment 100
#4
AMZN
score 38.8
5/5 inputs
Ranks last as zero momentum score from flat 1-month performance kills weighted result despite 67 quality rating.
value 25growth 50quality 67momentum 0sentiment 67
#1
JNJ
score 69.4
3/5 inputs
Ranks first with highest 79 quality score driving overall performance alongside balanced 55 momentum and 79 sentiment.
quality 79momentum 55sentiment 79
BAYRY
Bayer Aktiengesellschaft
$13.80
+1.47%
Snapshot
Price 13.8
Day % 1.47
1M % 32.95
3M % 16.95
YTD % 24.44
Market cap 54229807104.0
ADV ($) 19244983.465991974
Beta 0.83
OdysseyHQ zone
Current zone Extended
Dist 21-EMA % 4.01
Dist ATR (σ) 1.34
OdysseyHQ grade
Confluence 1
Valuation
P/E (ttm)
P/E (fwd) 11.139633
P/S 1.1986607
EV/EBITDA 8.523
P/B 1.6485983
FCF yield 0.1349
PEG 4.61
Growth
Revenue yoy -0.024
EPS yoy 1.129
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.59918
Operating margin 0.26319
Net margin -0.04765
ROE -0.06928
ROA 0.03637
Debt / Equity 1.34
Interest cov. -0.38
Technicals
RSI(14) 61.7
MACD signal neutral
vs 50-DMA 17.38
vs 200-DMA 26.78
vs 52w high -9.39
HV-30 59.0
Sentiment
Analyst rec 2.25
Target upside 10.33
Insider buy-sell 90d
Risk
Short interest
Days to cover 0.0
Next earnings 2026-08-04
Full BAYRY dashboard →
UNH
UNH
$426.09
+0.64%
Snapshot
Price 426.09
Day % 0.64
1M % 4.52
3M % 34.67
YTD % 26.66
Market cap
ADV ($)
Beta
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 1.78
Dist ATR (σ) 0.6
OdysseyHQ grade C
Confluence 3
Valuation
P/E (ttm)
P/E (fwd)
P/S
EV/EBITDA
P/B
FCF yield
PEG
Growth
Revenue yoy
EPS yoy
FCF yoy
Revenue trend 8Q
Quality
Gross margin
Operating margin
Net margin
ROE
ROA
Debt / Equity
Interest cov. 4.67
Technicals
RSI(14) 57.9
MACD signal neutral
vs 50-DMA 5.76
vs 200-DMA 24.8
vs 52w high -7.7
HV-30 26.9
Sentiment
Analyst rec
Target upside
Insider buy-sell 90d 23
Risk
Short interest
Days to cover
Next earnings
Full UNH dashboard →
AMZN
Amazon.com, Inc.
$247.23
-1.06%
Snapshot
Price 247.23
Day % -1.06
1M % 0.5
3M % -0.99
YTD % 9.15
Market cap 2659480240128.0
ADV ($) 12189345134.532013
Beta 1.461
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 0.6
Dist ATR (σ) 0.19
OdysseyHQ grade
Confluence 1
Valuation
P/E (ttm) 29.572968
P/E (fwd) 24.94745
P/S 3.5804608
EV/EBITDA 17.656
P/B 6.016353
FCF yield 0.0037
PEG 1.3
Growth
Revenue yoy 0.166
EPS yoy 0.748
FCF yoy
Revenue trend 8Q
Quality
Gross margin 0.50604
Operating margin 0.1314
Net margin 0.12224
ROE 0.24285
ROA 0.06845
Debt / Equity 0.53
Interest cov. 43.79
Technicals
RSI(14) 51.3
MACD signal bull
vs 50-DMA -1.94
vs 200-DMA 5.63
vs 52w high -11.25
HV-30 32.8
Sentiment
Analyst rec 1.30769
Target upside 27.1
Insider buy-sell 90d -24
Risk
Short interest 1.0199999
Days to cover 1.6
Next earnings 2026-07-30
Full AMZN dashboard →
JNJ
JNJ
$253.04
+1.23%
Snapshot
Price 253.04
Day % 1.23
1M % 7.59
3M % 7.89
YTD % 22.04
Market cap
ADV ($)
Beta
OdysseyHQ zone
Current zone Neutral
Dist 21-EMA % 0.93
Dist ATR (σ) 0.38
OdysseyHQ grade
Confluence 1
Valuation
P/E (ttm)
P/E (fwd)
P/S
EV/EBITDA
P/B
FCF yield
PEG
Growth
Revenue yoy
EPS yoy
FCF yoy
Revenue trend 8Q
Quality
Gross margin
Operating margin
Net margin
ROE
ROA
Debt / Equity
Interest cov. 34.55
Technicals
RSI(14) 54.4
MACD signal neutral
vs 50-DMA 6.03
vs 200-DMA 13.51
vs 52w high -6.08
HV-30 29.3
Sentiment
Analyst rec
Target upside
Insider buy-sell 90d 13
Risk
Short interest
Days to cover
Next earnings
Full JNJ dashboard →

Earnings replay · last 0 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

No earnings history available.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
BAYRY $54B 11.1 1.2 8.5 1.6 59.9% -2.4% 112.9% 13.49%
LLY $1,051B 41.8 26.3 14.6 30.1 33.8 82.8% 55.5% 169.9% 0.87%
UNH $387B 32.1 19.2 0.9 17.7 4.0 19.5% 0.4% 61.5% 5.88%
JNJ $609B 29.3 19.7 6.2 18.4 7.5 68.1% 6.6% -1.0%
MRK $315B 36.0 13.2 4.8 12.1 6.9 76.7% 4.9% 4.46%
ABBV $450B 124.8 15.6 7.2 17.2 -67.6 72.0% 12.4% -46.2% 4.63%
PFE $143B 19.1 8.8 2.3 7.6 1.6 74.8% 5.4% -10.1% 8.67%
TMO $198B 29.2 19.5 4.4 21.1 3.8 40.9% 6.2% 11.3% 2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 0.17%

HolderShares% out
Kahn Brothers Group Inc. 6,513,893 0.17%
Westside Investment Management, Inc. 2,878
PNC Financial Services Group, Inc. 3,030
Atlas Capital Advisors Inc 35,510
Great Lakes Advisors LLC 119,517
Rhumbline Advisers 68,123
Salomon & Ludwin, LLC 2,141
Gamma Investing LLC 41,204
Chicago Trust Co Na 20,097
Sterling Capital Management, LLC 846

Insider activity · 90d

No insider trades for BAYRY in last 90d.

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$14.5
Mean
$15.225
High
$15.8
Analysts
4
Recommendation distribution · period 2026-07-01
6
15
7
Revision trend (2026-04-01 → 2026-07-01): net 19 → 21 +2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

No CIK found for BAYRY.

About BAYRY

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmaci…

Options picks · BAYRY

ITM + OTM ideas from the latest scan

Loading…

Congress trades · BAYRY

STOCK Act disclosures

Loading…

SEC filings & insiders · BAYRY

EDGAR · live

Loading…

Holders · BAYRY

Institutions & insider activity

Loading…